151:
Gelesis
Holdings, Inc. together with its two affiliates, filed for voluntary Chapter 7 liquidation in the United States Bankruptcy Court for the District of Delaware on October 30, 2023. The debtor listed its assets among the 50 and the $ 100 million and liabilities of $ 44.34 million. The Debtor is
187:
In March 2015, the company closed a $ 22 million funding round. In April 2015, the company announced an initial public offering (IPO) for $ 60 million, but pulled out later that year. In
December 2015, Gelesis raised $ 31.5 million shortly after cancelling its IPO.
647:
160:
Gelesis was founded by PureTech
Ventures, a life sciences venture firm based in Boston, and ExoTech Bio, an Israel-based research and development company. The company operates as an affiliate of
194:
In
January 2022, the company completed a business combination with Capstar Special Purpose Acquisition Corp. and commenced trading on the New York Stock Exchange under the ticker symbol “GLS."
219:
339:
689:
704:
599:
694:
144:
capsule that expands in the stomach, creating a feeling of fullness, helping people reduce the amount of food they eat. The company was founded in 2006 to develop
549:
709:
648:"Gelesis®, the Maker of Plenity® for Weight Management, Will Debut as a Publicly Traded Company Following the Closing of Its Business Combination with Capstar"
181:
In 2010, the company passed the first human trials of its treatment. The company’s product was originally called Attiva, but was later renamed
Gelesis100.
383:
238:
431:
522:
573:
474:
191:
In 2018, Gelesis raised $ 30 million in preparation for regulatory submissions in the U.S. and Europe and initial marketing of
Gelesis100.
699:
449:
314:
288:
623:
265:
184:
In 2014, Gelesis raised $ 12 million in its fifth funding round, bringing its total funding to $ 42 million.
92:
37:
550:"Gelesis drops IPO, raises $ 31.5M for pivotal U.S. trial of hydrogel weight-loss capsule | FierceBiotech"
168:
125:
74:
167:
The company's technology was co-invented by
Alessandro Sannino, a professor of engineering at the
357:
498:
175:
369:
164:. Former PureTech Ventures partner Yishai Zohar co-founded the company and served as CEO.
161:
145:
220:"Obesity Capsule From Gelesis, Made to Swell Up in the Stomach, Passes First Human Trial"
384:"Anti-Obesity Pill Swells in Your Stomach, Making You Full Before You Even Start Eating"
407:
174:
In
January 2008, the company raised $ 16 million in its first financing round, led by
683:
78:
55:
31:
152:
represented by
Kenneth Listwak of Troutman Pepper Hamilton Sanders LLP as counsel.
96:
574:"Xconomy: Months After Postponed IPO, Gelesis Nabs $ 31.5M And a New Investor"
133:
129:
51:
523:"Company with obesity treatment raises $ 31.5M on heels of withdrawn IPO"
141:
624:"Gelesis raises $ 30M to gear up for weight loss launch | FierceBiotech"
432:"The Daily Startup: Medtronic Spinout Raises $ 40M to Treat Sleep Apnea"
600:"In Two Months, Biotech Startups Raised More Money Than In All Of 2013"
137:
450:"Xconomy: Gelesis Resurfaces With $ 12M, Preps First Weight Loss Data"
239:"Early Results Arrive on Weight-Loss Pills That Expand in the Stomach"
41:
340:"PureTech's Gelesis says obesity drug achieved weight loss in study"
171:, who had been researching the idea prior to the launch of Gelesis.
289:"Xconomy: Obesity Startup Gelesis Gobbles Up $ 16M in Financing"
315:"Gelesis raises $ 30 million to fund novel weight loss therapy"
266:"Gelesis raises $ 12 million for pill that staves off hunger"
140:. The company produces Gelesis100, which is a superabsorbent
674:
108:
408:"Hydrogel 'smart pill' shows promise as weight loss aid"
103:
85:
69:
61:
47:
29:
21:
475:"Boston weight-loss biotech Gelesis raises $ 22M"
91:John LaMattina, PhD – Chairman, Yishai Zohar -
99:, David Pass, PharmD – Chief Operating Officer
8:
690:Biotechnology companies of the United States
16:
705:Biotechnology companies established in 2008
15:
203:
695:American companies established in 2008
365:
355:
128:that developed the weight loss device
124:is a biotechnology company located in
544:
542:
7:
710:2008 establishments in Massachusetts
283:
281:
279:
260:
258:
213:
211:
209:
207:
218:Timmerman, Luke (April 22, 2010).
14:
499:"Term Sheet -- Thursday, April 2"
178:and Queensland BioCapital Funds.
237:Pollack, Andrew (23 June 2014).
1:
148:and treatments for obesity.
726:
700:Companies based in Boston
675:http://www.gelesis.com/
319:www.thepharmaletter.com
628:www.fiercebiotech.com
554:www.fiercebiotech.com
169:University of Salento
132:(Plenity) for use in
126:Boston, Massachusetts
75:Boston, Massachusetts
313:Letter, The Pharma.
527:www.bizjournals.com
479:www.bizjournals.com
338:Reuters Editorial.
18:
412:Medical News Today
368:has generic name (
243:The New York Times
598:Herper, Matthew.
119:
118:
717:
662:
661:
659:
658:
644:
638:
637:
635:
634:
620:
614:
613:
611:
610:
595:
589:
588:
586:
585:
570:
564:
563:
561:
560:
546:
537:
536:
534:
533:
519:
513:
512:
510:
509:
495:
489:
488:
486:
485:
471:
465:
464:
462:
461:
446:
440:
439:
428:
422:
421:
419:
418:
404:
398:
397:
395:
394:
380:
374:
373:
367:
363:
361:
353:
351:
350:
335:
329:
328:
326:
325:
310:
304:
303:
301:
300:
285:
274:
273:
262:
253:
252:
250:
249:
234:
228:
227:
215:
176:OrbiMed Advisors
115:
112:
110:
19:
725:
724:
720:
719:
718:
716:
715:
714:
680:
679:
671:
666:
665:
656:
654:
646:
645:
641:
632:
630:
622:
621:
617:
608:
606:
597:
596:
592:
583:
581:
572:
571:
567:
558:
556:
548:
547:
540:
531:
529:
521:
520:
516:
507:
505:
497:
496:
492:
483:
481:
473:
472:
468:
459:
457:
448:
447:
443:
438:. May 16, 2014.
430:
429:
425:
416:
414:
406:
405:
401:
392:
390:
388:Popular Science
382:
381:
377:
364:
354:
348:
346:
337:
336:
332:
323:
321:
312:
311:
307:
298:
296:
287:
286:
277:
272:. May 16, 2014.
264:
263:
256:
247:
245:
236:
235:
231:
217:
216:
205:
200:
162:PureTech Health
158:
146:medical devices
107:
88:
81:
34:
12:
11:
5:
723:
721:
713:
712:
707:
702:
697:
692:
682:
681:
678:
677:
670:
669:External links
667:
664:
663:
652:ir.gelesis.com
639:
615:
590:
565:
538:
514:
490:
466:
441:
423:
399:
375:
330:
305:
275:
270:BetaBoston.com
254:
229:
202:
201:
199:
196:
157:
154:
117:
116:
105:
101:
100:
89:
86:
83:
82:
73:
71:
67:
66:
63:
59:
58:
49:
45:
44:
35:
30:
27:
26:
23:
13:
10:
9:
6:
4:
3:
2:
722:
711:
708:
706:
703:
701:
698:
696:
693:
691:
688:
687:
685:
676:
673:
672:
668:
653:
649:
643:
640:
629:
625:
619:
616:
605:
601:
594:
591:
579:
575:
569:
566:
555:
551:
545:
543:
539:
528:
524:
518:
515:
504:
500:
494:
491:
480:
476:
470:
467:
455:
451:
445:
442:
437:
433:
427:
424:
413:
409:
403:
400:
389:
385:
379:
376:
371:
366:|author=
359:
345:
341:
334:
331:
320:
316:
309:
306:
294:
290:
284:
282:
280:
276:
271:
267:
261:
259:
255:
244:
240:
233:
230:
225:
221:
214:
212:
210:
208:
204:
197:
195:
192:
189:
185:
182:
179:
177:
172:
170:
165:
163:
155:
153:
149:
147:
143:
139:
135:
131:
127:
123:
114:
106:
102:
98:
94:
90:
84:
80:
76:
72:
68:
64:
60:
57:
56:Biotechnology
53:
50:
46:
43:
39:
36:
33:
28:
24:
20:
655:. Retrieved
651:
642:
631:. Retrieved
627:
618:
607:. Retrieved
603:
593:
582:. Retrieved
580:. 2015-12-18
577:
568:
557:. Retrieved
553:
530:. Retrieved
526:
517:
506:. Retrieved
502:
493:
482:. Retrieved
478:
469:
458:. Retrieved
456:. 2014-05-16
453:
444:
435:
426:
415:. Retrieved
411:
402:
391:. Retrieved
387:
378:
347:. Retrieved
343:
333:
322:. Retrieved
318:
308:
297:. Retrieved
295:. 2008-01-03
292:
269:
246:. Retrieved
242:
232:
223:
193:
190:
186:
183:
180:
173:
166:
159:
150:
121:
120:
70:Headquarters
22:Company type
684:Categories
657:2022-01-18
633:2018-03-05
609:2018-03-05
584:2018-09-28
559:2018-09-28
532:2018-09-28
508:2018-09-28
484:2018-09-28
460:2018-09-27
417:2018-09-28
393:2018-09-28
349:2018-09-28
324:2018-09-28
299:2018-09-28
248:2018-09-28
198:References
134:overweight
130:Gelesis100
87:Key people
52:Healthcare
358:cite news
32:Traded as
142:hydrogel
111:.gelesis
48:Industry
578:Xconomy
503:Fortune
454:Xconomy
436:WSJ.com
293:Xconomy
224:Xconomy
156:History
138:obesity
122:Gelesis
104:Website
97:Founder
62:Founded
40::
25:Private
17:Gelesis
604:Forbes
370:help
136:and
113:.com
95:and
65:2006
38:NYSE
344:U.S
109:www
93:CEO
79:USA
42:GLS
686::
650:.
626:.
602:.
576:.
552:.
541:^
525:.
501:.
477:.
452:.
434:.
410:.
386:.
362::
360:}}
356:{{
342:.
317:.
291:.
278:^
268:.
257:^
241:.
222:.
206:^
77:,
54:,
660:.
636:.
612:.
587:.
562:.
535:.
511:.
487:.
463:.
420:.
396:.
372:)
352:.
327:.
302:.
251:.
226:.
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.